Skip to main content

Advertisement

Log in

ILP and RT: The Study That Will Never Be

  • Bone and Soft Tissue Sarcomas
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Deroose JP, Burger JWA, van Geel AN, et al. Radiotherapy for soft tissue sarcoma after isolated limb perfusion and surgical resection: essential for local control in all patients? Ann Surg Oncol. 2010. doi: 10.1245/s10434-010-1400-x.

  2. Eggermont AM, Schraffordt Koops H, Klausner JM, et al. Isolated limb perfusion with tumor necrosis factor and melphalan for limb salvage in 186 patients with locally advanced soft tissue extremity sarcomas. The cumulative multicenter European experience. Ann Surg. 1996;224:756–64.

    CAS  Google Scholar 

  3. Lejeune FJ, Pujol N, Lienard D, et al. Limb salvage by neoadjuvant isolated perfusion with TNFa and melphalan for non-resectable soft tissue sarcomas of the extremities. Eur J Surg Oncol. 2000;26:669–78.

    Article  CAS  PubMed  Google Scholar 

  4. Bonvalot S, Rimareix F, Causeret S, et al. Hyperthermic isolated limb perfusion in locally advanced soft tissue sarcoma and progressive desmoid-type fibromatosis with TNF 1 mg and melphalan (T1-M HILP) is safe and efficient. Ann Surg Oncol. 2009;16:3350–7.

    Article  PubMed  Google Scholar 

  5. Hayes AJ, Neuhaus SJ, Clark MA, et al. Isolated limb perfusion with Melphalan and tumor necrosis factor alpha for advanced melanoma and soft tissue sarcoma. Ann Surg Oncol. 2007;14:230–8.

    Article  PubMed  Google Scholar 

  6. Pennacchioli E, Deraco M, Mariani L, et al. Advanced extremity soft tissue sarcoma: prognostic effect of isolated limb perfusion in a series of 88 patients treated at a single institution. Ann Surg Oncol. 2007;14:553–9.

    Article  PubMed  Google Scholar 

  7. van Ginkel RJ, Thijssens KM, Pras E, et al. Isolated limb perfusion with tumor necrosis factor alpha and melphalan for locally advanced soft tissue sarcoma: three time periods at risk for amputation. Ann Surg Oncol. 2007;14:1499–506.

    Article  PubMed  Google Scholar 

  8. Hohenberger P, et al. Functional outcome after preoperative isolated limb perfusion with rhTNFalpha/melphalan for high-grade extremity sarcoma. Eur J Cancer. 2001;37:S34–5.

    Article  Google Scholar 

  9. Grabellus F, Kraft C, Sheu SY, et al. Evaluation of 47 soft tissue sarcoma resection specimens after isolated limb perfusion with TNF-alpha and melphalan: histologically characterized improved margins correlate with absence of recurrences. Ann Surg Oncol. 2009;16:676–86.

    Article  PubMed  Google Scholar 

  10. Noorda EM, Vrouenraets BC, Nieweg OE, et al. Isolated limb perfusion with tumor necrosis factor-alpha and melphalan for patients with unresectable soft tissue sarcoma of the extremities. Cancer. 2003;98:1483–90.

    Article  CAS  PubMed  Google Scholar 

  11. Gronchi A, Palmerini E, Demetri G, et al. 2009. A phase II clinical trial of neoadjuvant trabectedin in patients with non metastatic advanced myxoid/round cell liposarcoma (MRCL). Eur J Cancer. 7: 589.

    Google Scholar 

  12. Thijssens KM, van Ginkel RJ, Pras E, Suurmeijer AJ, Hoekstra HJ. Isolated limb perfusion with tumor necrosis factor alpha and melphalan for locally advanced soft tissue sarcoma: the value of adjuvant radiotherapy. Ann Surg Oncol. 2006;13:518–24.

    Article  PubMed  Google Scholar 

  13. Muret J, Yacoub M, Terrier P, et al. p53 status correlates with histopathological response in patients with soft tissue sarcomas treated using isolated limb perfusion with TNF-alpha and melphalan. Ann Oncol. 2008;19:793–800.

    Article  CAS  PubMed  Google Scholar 

  14. Hoven-Gondrie ML, Thijssens KM, Van den Dungen JJ, et al. Long-term locoregional vascular morbidity after isolated limb perfusion and external-beam radiotherapy for soft tissue sarcoma of the extremity. Ann Surg Oncol. 2007;14:2105–12.

    Article  PubMed  Google Scholar 

  15. Pisters PW, Pollock RE, Lewis VO, et al. Long-term results of prospective trial of surgery alone with selective use of radiation for patients with T1 extremity and trunk soft tissue sarcomas. Ann Surg. 2007;246:675–81.

    Article  PubMed  Google Scholar 

  16. Gronchi A, Lo Vullo S, Colombo C, et al. Extremity soft tissue sarcoma in a series of patients treated at a single institution: local control directly impacts survival. Ann Surg. 2010;251:506–11.

    Article  PubMed  Google Scholar 

  17. Bonvalot S, Dunant A, le Pechoux C, et al. Quality of surgical margins and local recurrence in primary extremity soft tissue sarcoma (STS). J Clin Oncol. 2010;28(15_suppl):10068.

    Google Scholar 

Download references

Conflicts of interest

The authors declare no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Alessandro Gronchi MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bonvalot, S., Gronchi, A. ILP and RT: The Study That Will Never Be. Ann Surg Oncol 18, 303–305 (2011). https://doi.org/10.1245/s10434-010-1461-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-010-1461-x

Navigation